Heart Test Laboratories Inc. (NASDAQ:HSCS) traded at $0.10 at close of the session on Monday, April 29, made a downward move of -1.03% on its previous day’s price.
Looking at the stock we see that its previous close was $0.10. In terms of its 52-week price range, HSCS has a high of $1.32 and a low of $0.09. The company’s stock has lost about -17.54% over that past 30 days.
Heart Test Laboratories Inc. has a market cap of $6.32 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.03, with the EPS growth for the year raised at -$0.2 for 2024 and -$0.1 for next year. These figures represent 75.00% and 50.00% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $50k, with a high of $100k. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $60k, or 1,100.00% up from figures reported last year.
On the other hand, looking at the outlook for the HSCS stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -8.45% off its SMA20 and -17.11% from its 50-day simple moving average. The RSI (14) is pointing at 39.16 while the volatility over the past week is 10.53% and jumps to 8.90% over the past one month. The beta value is 3.43, while the average true range (ATR) is currently pointing at 0.01.
Coming back to Heart Test Laboratories Inc. (NASDAQ:HSCS), we note that the average 3-month trading volume was 1.91 million. Current shares outstanding are 65.56 million.
The insiders hold 16.16% of the company’s shares while institutions hold 1.84%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -43.63% down in year-to-date price movement.
